Trevena, Inc. (TRVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: March 17, 2016
Pages: 26
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: T4650F1A1ACEN
Leaflet:

Download PDF Leaflet

Trevena, Inc. (TRVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Trevena, Inc. (Trevena) is a biopharmaceutical company that discovers and develops next generation of G-protein coupled receptor (GPCR) targeted medicines. The company’s products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure (AHF) in combination with standard diuretic therapy. Trevena’s TRV130 is an intravenous G protein biased ligand that targets the mu opioid receptor. The company’s T RV734 is a small molecule G protein biased ligand at the mu-opioid receptor to treat moderate to severe acute and chronic pain. Its GPCR is associated with beneficial versus adverse biological effects. Trevena is headquartered in King of Prussia, Pennsylvania, the US.

Trevena, Inc. (TRVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deal Details
Venture Financing
Trevena To Raise US$60 Million In Series C Financing
Trevena Raises US$35 Million In Series B Financing
Partnerships
Trevena Enters Into Research Agreement With Merck For Biased Ligand Molecules
Licensing Agreements
Trevena Enters Into Option Agreement With Forest Labs To License TRV027
Equity Offering
Trevena Raises USD73 Million in Public Offering of Shares
Trevena Raises USD51.4 Million in Public Offering of Shares
Trevena Completes Underwriters Exercise Of Over-Allotment Of IPO For US$66.6 Million
Trevena, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer 26

LIST OF TABLES

Trevena, Inc., Pharmaceuticals & Healthcare, Key Facts, 2014
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Trevena, Inc., Deals By Therapy Area, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016
Trevena To Raise US$60 Million In Series C Financing
Trevena Raises US$35 Million In Series B Financing
Trevena Enters Into Research Agreement With Merck For Biased Ligand Molecules
Trevena Enters Into Option Agreement With Forest Labs To License TRV027
Trevena Raises USD73 Million in Public Offering of Shares
Trevena Raises USD51.4 Million in Public Offering of Shares
Trevena Completes Underwriters Exercise Of Over-Allotment Of IPO For US$66.6 Million
Trevena, Inc., Key Competitors
Trevena, Inc., Key Employees 24

LIST OF FIGURES

Trevena, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016
Trevena, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016
Skip to top


Ask Your Question

Trevena, Inc. (TRVN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: